Covered recipient · General Payments record
DANIEL DAWSON
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$3,639.63
- Reported across 81 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $965.64 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $418.26 | 15 |
| GLAUKOS CORPORATION | $151.61 | 1 |
| Alcon Laboratories Inc | $128.87 | 3 |
| Apellis Pharmaceuticals, Inc. | $121.82 | 1 |
| Oyster Point Pharma, Inc. | $47.63 | 2 |
| Sight Sciences, Inc. | $26.35 | 1 |
| Amgen Inc. | $23.10 | 1 |
| RxSight Inc | $19.49 | 1 |
| Dompe US, Inc. | $14.38 | 1 |
| Bausch & Lomb Americas Inc. | $14.13 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 20182019202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $33.67 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611420 | CMS |
| ABBVIE INC. | $31.41 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611422 | CMS |
| ABBVIE INC. | $31.34 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611424 | CMS |
| ABBVIE INC. | $32.12 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611426 | CMS |
| ABBVIE INC. | $28.86 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611428 | CMS |
| ABBVIE INC. | $32.13 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611430 | CMS |
| ABBVIE INC. | $33.05 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611432 | CMS |
| ABBVIE INC. | $32.90 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611434 | CMS |
| ABBVIE INC. | $20.13 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611436 | CMS |
| ABBVIE INC. | $23.38 | 08/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611438 | CMS |
| ABBVIE INC. | $32.63 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611440 | CMS |
| ABBVIE INC. | $34.11 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611442 | CMS |
| ABBVIE INC. | $33.80 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611444 | CMS |
| ABBVIE INC. | $1.03 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611446 | CMS |
| ABBVIE INC. | $17.70 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103611448 | CMS |
| Alcon Vision LLC | $19.89 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110703100 | CMS |
| Alcon Vision LLC | $16.46 | 03/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110703098 | CMS |
| Alcon Vision LLC | $92.52 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110703102 | CMS |
| Amgen Inc. | $23.10 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111559762 | CMS |
| Apellis Pharmaceuticals, Inc. | $121.82 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154019092 | CMS |
| Bausch & Lomb Americas Inc. | $14.13 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140328729 | CMS |
| Dompe US, Inc. | $14.38 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151400971 | CMS |
| Glaukos Corporation | $151.61 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151988960 | CMS |
| Oyster Point Pharma, Inc. | $23.72 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147418039 | CMS |
| Oyster Point Pharma, Inc. | $23.91 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147418049 | CMS |
| RxSight Inc | $19.49 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144215286 | CMS |
| Sight Sciences, Inc. | $26.35 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151925086 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.